Japan Essentials - 10 Jul 2026

Research evidence excerpt

Japan Essentials - 10 Jul 2026

Macquarie Equity Research

09 July 2026

Equity Strategy

ASEANMalaysia Strategy

MY Value Up: Feedback from corporates

Andrew Amanda

Key Points San, CFA Foo

• We sought feedback from corporates regarding MY Value Up (MYVU)

via a survey of 45 Bursa-listed companies. Interest in the program was

Izzati Colin

evident. Hakim, CFA Lee

• Improved visibility with investors was the most widely expected benefit

of participating in MYVU. Tax relief was the most valued incentive. Figure 2 - Key MY Value Up

• Concerns about revealing strategy to competitors and a lack beneficiaries

of understanding of MYVU's benefits were seen as the greatest Fundamental Undervalued

implementation challenges. Sector but sound upside Low liquidity

potential

MAY, PBK,

Financials

• We surveyed 45 Bursa-listed companies (mostly >RM4b mkt cap) to HLBK

assess their interest in MYVU, its perceived benefits, implementation Telcos MAXIS, TM TDC

challenges, and most valued incentives. There was strong willingness to Healthcare IHH

participate in MYVU, with 87% of respondents indicating interest in the Materials PCHEM

program, while the remaining 13% (predominantly non-GLCs) were either Utilities YTLP

undecided or not interested. Consumers MRDIY

• Respondents viewed MYVU's potential to enhance investor visibility Planters SDG KLK Tech VITRO

as a key 'value add', e.g., through increased analyst coverage, stronger

trading liquidity, and access to a broader investor base. Smaller-cap Source: Macquarie Research, July 2026

companies in the sample (<RM10b mkt cap) and non-GLCs viewed scope

for improved valuations and financial performance as the primary benefit Related reports:

• Malaysia Strategy - MY Value Up: Identifying key of MYVU participation. beneficiaries